The impact of cyclooxygenase inhibitor use on urinary prostaglandin metabolites in preterm infants

The impact of cyclooxygenase inhibitor use on urinary prostaglandin metabolites in preterm infants

Background: There is limited evidence on the association between the clinical course of patent ductus arteriosus (PDA) and prostaglandin (PG) metabolites. This study aimed to determine the influence of PDA treatment on urinary PG metabolite excretion in very-low-birth-weight (VLBW) infants. Methods:...

全面介绍

书目详细资料
Main Authors: Natsuki Ohkawa, Hiromichi Shoji, Naho Ikeda, Yayoi Murano, Toshiaki Okuno, Masato Kantake, Takehiko Yokomizo, Toshiaki Shimizu
格式: 文件
语言:English
出版: Elsevier 2024-03-01
丛编:Pediatrics and Neonatology
主题:
cyclooxygenase-2 inhibitor
ductus arteriosus
infant
preterm infant
prostaglandins
在线阅读:http://www.sciencedirect.com/science/article/pii/S1875957223001328

因特网

http://www.sciencedirect.com/science/article/pii/S1875957223001328

相似书籍